首页> 外文OA文献 >Efficacy of lorlatinib treatment in ALK rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status

【2h】

Efficacy of lorlatinib treatment in ALK rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status

机译：洛拉替尼治疗在ALK重排肺癌中的功效具有严重的症状中枢神经系统转移及性能状况差

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tomoyo Taketa; Takahito Nakamura;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P2.01-84 Patterns of Central Nervous System Metastases in EGFR Mutated or ALK Rearranged Non Small Cell Lung Cancer Patients [J] . M. Sharma, U. Batra, P. Jain, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：EGFR突变或ALK重新排列非小细胞肺癌患者中枢神经系统转移的P2.01-84
2. Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique [J] . M. Nico?, P. Krawczyk, K. Wojas-Krawczyk, Clinical & translational oncology : . 2017,第12期

机译：使用两步RT-PCR技术评价非小细胞肺癌中枢神经系统转移中的ALK基因重转移
3. Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria [J] . Gandhi Leena, Ou Sai-Hong Ignatius, Shaw Alice T., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：邻苯胺在屈尿层抗性ALK阳性非小细胞癌中的中枢神经系统转移中的疗效：RECIST 1.1和RANO-HGG标准的比较
4. High throughput multiplexed phosphoproteomics identifies drivers of resistance to ALK inhibitor treatment in lung cancer [C] . Amanda L. Edwards, Luc Friboulet, Rosa Frias, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：高通量复用磷蛋白酶鉴定肺癌抗华抗抑制剂治疗的驱动因素
5. Fatigue, self-efficacy, and physical functional status in persons with lung cancer. [D] . Hoffman, Amy Jude. 2007

机译：肺癌患者的疲劳，自我效能和身体功能状态。
6. Efficacy of lorlatinib treatment in ALK rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status [O] . Tomoyo Taketa, Takahito Nakamura 2021

机译：洛拉替尼治疗在ALK重排肺癌中的功效具有严重的症状中枢神经系统转移及性能状况差
7. Efficacy of lorlatinib treatment in ALK-rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status [O] . Tomoyo Taketa, Takahito Nakamura 2020

机译：洛拉替尼治疗在ALK重排肺癌中的疗效，具有严重的症状中枢神经系统转移和差的性能状况

Efficacy of lorlatinib treatment in ALK rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status

著录项

引文网络

相似文献

相关主题

期刊订阅